Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
107516426 | 10751642 | 6 | F | 20150126 | 20160907 | 20150130 | 20160914 | EXP | US-PFIZER INC-2015042374 | PFIZER | 72.00 | YR | F | Y | 81.00000 | KG | 20160914 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
107516426 | 10751642 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 300 MG, 2X/DAY | N | 21446 | 300 | MG | CAPSULE, HARD | BID | |||||
107516426 | 10751642 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 600 MG, DAILY | N | N17638 | 21446 | 600 | MG | CAPSULE, HARD | |||||
107516426 | 10751642 | 3 | SS | LYRICA | PREGABALIN | 1 | 300 MG, DAILY | N | 21446 | 300 | MG | CAPSULE, HARD | |||||||
107516426 | 10751642 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | N | 21446 | 150 | MG | CAPSULE, HARD | TID | |||||
107516426 | 10751642 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 500 MG, 2X/DAY | 0 | 500 | MG | BID | ||||||||
107516426 | 10751642 | 6 | C | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | |||||||
107516426 | 10751642 | 7 | C | LOSARTAN/HCTZ | HYDROCHLOROTHIAZIDELOSARTAN | 1 | 1 DF, DAILY [HYDROCHLOROTHIAZIDE: 25MG]/[LOSARTAN POTASSIUM: 100MG] | 0 | 1 | DF | TABLET | ||||||||
107516426 | 10751642 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0.175 MG, 1X/DAY | 0 | .175 | MG | QD | ||||||||
107516426 | 10751642 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 20 MG, 1X/DAY (ONE TABLET, IN EVENING) | 0 | 20 | MG | TABLET | QD | |||||||
107516426 | 10751642 | 10 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK, UP TO 4X/DAY | 0 | QID | ||||||||||
107516426 | 10751642 | 11 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
107516426 | 10751642 | 12 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | UNK, 1X/DAY (AT NIGHT) | 0 | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
107516426 | 10751642 | 1 | Neuropathy peripheral |
107516426 | 10751642 | 2 | Neuralgia |
107516426 | 10751642 | 5 | Diabetes mellitus |
107516426 | 10751642 | 6 | Blood pressure abnormal |
107516426 | 10751642 | 7 | Blood pressure abnormal |
107516426 | 10751642 | 8 | Thyroid disorder |
107516426 | 10751642 | 10 | Back pain |
107516426 | 10751642 | 11 | Neck pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
107516426 | 10751642 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
107516426 | 10751642 | Drug ineffective | |
107516426 | 10751642 | Fall | |
107516426 | 10751642 | Joint injury | |
107516426 | 10751642 | Lung disorder | |
107516426 | 10751642 | Malaise | |
107516426 | 10751642 | Pain in extremity | |
107516426 | 10751642 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |